1. Home
  2. GBDC vs TMDX Comparison

GBDC vs TMDX Comparison

Compare GBDC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golub Capital BDC Inc.

GBDC

Golub Capital BDC Inc.

HOLD

Current Price

$13.57

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$122.36

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBDC
TMDX
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.9B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
GBDC
TMDX
Price
$13.57
$122.36
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$14.83
$144.25
AVG Volume (30 Days)
2.0M
664.3K
Earning Date
02-03-2026
10-29-2025
Dividend Yield
11.50%
N/A
EPS Growth
4.09
170.70
EPS
1.42
2.54
Revenue
$870,777,000.00
$566,354,000.00
Revenue This Year
N/A
$38.81
Revenue Next Year
N/A
$20.49
P/E Ratio
$9.58
$47.97
Revenue Growth
20.16
41.20
52 Week Low
$12.68
$55.00
52 Week High
$16.01
$156.00

Technical Indicators

Market Signals
Indicator
GBDC
TMDX
Relative Strength Index (RSI) 41.32 42.29
Support Level $13.44 $121.00
Resistance Level $13.65 $133.29
Average True Range (ATR) 0.20 4.84
MACD -0.02 -0.91
Stochastic Oscillator 24.77 21.93

Price Performance

Historical Comparison
GBDC
TMDX

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: